TSO3 Inc. (TSE:TOS) – Stock analysts at Desjardins upped their FY2017 earnings estimates for shares of TSO3 in a research note issued to investors on Wednesday. Desjardins analyst F. Tremblay now expects that the company will post earnings per share of ($0.10) for the year, up from their prior estimate of ($0.11). Desjardins has a “Buy” rating and a $4.00 price objective on the stock. Desjardins also issued estimates for TSO3’s FY2018 earnings at ($0.06) EPS.
WARNING: “Research Analysts Offer Predictions for TSO3 Inc.’s FY2017 Earnings (TOS)” was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this report can be accessed at https://www.dispatchtribunal.com/2017/11/12/research-analysts-offer-predictions-for-tso3-inc-s-fy2017-earnings-tos.html.
Shares of TSO3 (TSE:TOS) opened at C$2.49 on Friday. TSO3 has a 12 month low of C$2.05 and a 12 month high of C$3.36.
In other news, Director Richard Mark Rumble purchased 22,000 shares of the company’s stock in a transaction on Wednesday, August 23rd. The shares were purchased at an average price of C$2.23 per share, with a total value of C$49,060.00.
TSO3 Inc is a Canada-based company engaged in the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment.
Receive News & Ratings for TSO3 Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TSO3 Inc. and related companies with MarketBeat.com's FREE daily email newsletter.